+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


2018 Laboratory Market Report

  • ID: 4603992
  • Report
  • August 2018
  • Region: Global
  • 36 Pages
  • Health Industry Distributors Association (HIDA)
1 of 2

The 2018 Laboratory Market Report looks at market growth and opportunities across major market segments; including hospital labs, physician office labs, and reference labs. The report also examines clinical trends including molecular testing, genetic testing, and companion diagnostics.

  • The medical laboratory testing market valued at $79 billion in 2017
  • Reimbursements cut for 75% of tests on the 2018 Clinical Laboratory Fee Schedule by the Center for Medicare and Medicaid Services
  • Genetic testing market grew 150% from 2012-2016

Who Should Buy This Report:

  • Healthcare investors
  • Health systems
  • Healthcare distributors
  • Healthcare manufactures
  • Group Purchasing Organizations
  • Government Health Agencies
  • State Health Agencies
  • Healthcare Providers
Note: Product cover images may vary from those shown
2 of 2
  • Executive Summary
  • Laboratory Market Overview
  • Hospital Lab Market Valued At $47 Billion
  • Hospital Lab Test Volumes Increase Five Consecutive Quarters
  • POL Market Grows $300 Million In 2017
  • POLs Make Up Nearly Half Of U.S. Laboratories
  • Drug Testing Spurs Growth In Number Of POLs
  • Quest Diagnostics, LabCorp Are Nearly Half Of Reference Lab Market By Revenue
  • LabCorp Increases Per Test Revenues
  • LabCorp Revenues 13.5% Higher Than Quest In 2017
  • Number Of Post-Acute Labs Up 12.5% From 2011 - 2018
  • CMS Relies Heavily On Reference Lab Data To Set Rates
  • Number Of CLFS Codes Up 18.4% From 2010
  • 75% Of Tests On CLFS To Receive Medicare Reimbursement Cuts Under PAMA
  • 20 Largest Payment Increases Under PAMA
  • 20 Largest Payment Decreases Under PAMA
  • Labs Work To Support Value Based Care Models
  • Medicare Spending On Lab Testing Down $200M From 2015–2016
  • Medicare Spending By Test
  • Drug, Molecular Pathology Testing Have Largest Medicare Spending Decreases
  • Payment, Coding May Differ Between Test Categories
  • POLs Most Vulnerable To Changes In Medicare  Reimbursement
  • Lab Tech Investment Benefits Hospitals
  • Lab Work Most Helpful Aspect Of EHR
  • Companion Diagnostics Compliment Pharmaceutical Therapy
  • Precision Medicine Market Projected To Exceed $2 Billion By 2022
  • Molecular Diagnostics Offer Early Detection
  • Syndromic Panel Testing: Multiple Diagnoses In One Test
  • Syndromic Panels May Lower Testing Costs
  • Majority Of Genetic Tests Are Single-Gene
  • Rapid Growth In Number Of Genetic Tests
  • Genetic Testing Could Reduce Treatment Costs
  • Genomic Testing Costs Rapidly Decline
  • Top 25 Tests Total 63% Of Medicare Lab Spend
  • Lab Supplies Purchased Through Distribution
  • Price Transparency Has No Impact On Clinician Test Ordering
  • GHX Market Breakdown Of Clinical Laboratory-Related Product Categories Sold Through Distribution
  • GHX Lists Clinical Laboratory Products Sold Through Distribution
  • Definitions
Note: Product cover images may vary from those shown
3 of 2